EKSO (Ekso Bionics Holdings, Inc. Common Stock) Stock Analysis - News
Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in EKSO news today?
Ekso Bionics to Merge with Applied Digital’s GPU Cloud Spin-Off ChronoScale in H1 2026: Applied Digital will spin off its GPU cloud business and merge it with Ekso Bionics to create a standalone entity named ChronoScale, with closing expected in H1 2026. Terms of the transaction and financing remain undisclosed, creating uncertainty around its impact on Ekso Bionics’s valuation.
Jones Jason C bought 1.31K (~$15.50K) on Mar 16, 2026.
Wong Jerome bought 1.31K (~$15.50K) on Mar 16, 2026.
ASHER DANIEL bought 15.54K (~$191.16K) on Feb 19, 2026.
EKSO Analyst Consensus
EKSO analyst coverage data. Average price target: $0.00.
Common questions about EKSO
What changed in EKSO news today?
Ekso Bionics to Merge with Applied Digital’s GPU Cloud Spin-Off ChronoScale in H1 2026: Applied Digital will spin off its GPU cloud business and merge it with Ekso Bionics to create a standalone entity named ChronoScale, with closing expected in H1 2026. Terms of the transaction and financing remain undisclosed, creating uncertainty around its impact on Ekso Bionics’s valuation.
Does Rallies summarize EKSO news?
Yes. Rallies summarizes EKSO news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is EKSO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EKSO. It does not provide personalized investment advice.
